Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes mellitus (LEAD-4 Met + TZD)
Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans
These findings provide valuable insights into what happens when treatment ends and weight regain dynamics come into play
Ongoing biomarker monitoring supports early detection of adverse changes and informs dose adjustments or discontinuation decisions
US$ 29.59
US$ 23.68
US$ 23.09
